Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Philips continues emerging markets expansion

This article was originally published in Clinica

Executive Summary

Philips has sealed its second Indian acquisition deal in as many months, after agreeing to buy X-ray systems manufacturer Meditronics for an undisclosed sum. Mumbai-based Meditronics develops general X-ray systems for the budget end of the market and has a strong focus on mobile C-arms (for surgery) and radiography. The company has around 150 employees and has four industrial sites across India. The deal comes two months after Philips agreed to buy Alpha X-Ray Technologies, another Indian company focusing on budget-end cardiovascular X-ray systems. Philips said it will leverage its global distribution network to expand its offering of economy X-ray products in other emerging and mature markets. Analysts estimate that the general X-ray segment of the Indian market will grow 10% or more each year, while the cardiovascular X-ray segment will grow by 10-15%.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT043252

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel